Early Periprosthetic Joint Infection and Outcome Debridement, Antibiotics and Implant Retention

Introduction Periprosthetic joint infection (PJI) is a severe complication to hip arthroplasty for femoral neck fractures (FNF). Debridement, antibiotics and implant retention (DAIR) is recommended in early PJI in association with stable implants. Few studies have evaluated the outcome of DAIR in this fragile population.The purpose of this study was to analyze risk factors for PJI and the short-term outcome of DAIR in FNF patients treated with a hip arthroplasty.

Methods A consecutive series of patients had been treated with either a total hip arthroplasty or a hemi hip arthroplasty for a displaced FNF at our institution. Data were retrospective analysed.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Femoral Neck Fracture Femoral Fractures Femoral Neck Fractures Fractures, Bone Hip Fractures Hip Injuries Infection Infections Leg Injuries Wounds and Injuries

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Displaced femoral neck fracture
Treated with a primary hip arthroplasty

Treatment and study plan

hip arthroplasty

Procedure

Treatment with a hip arthroplasty (semi- or total hip arthroplasty) for a displaced femoral neck fracture

Primary outcomes

Rate of periprosthetic joint infection

Time frame: 1 year

The incidence of periprosthetic joint infection

Secondary outcomes

The rate of healed periprosthetic joint infections after treatment with surgical debridement.

Time frame: 6 months

The rate of healed periprosthetic joint infections after treatment with surgical debridement.

Sponsors and collaborators

Lead sponsor

Sundsvall Hospital

Other

Registry information

Official study title

Early Periprosthetic Joint Infection and Debridement, Antibiotics and Implant Retention in Arthroplasty for Femoral Neck Fracture

Acronym: DAIR

Important dates

Study start: 2016
Primary completion: 2016
Study completion: 2016
First posted: May 13, 2016
Registry last updated: May 13, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed